Lixiana 60 mg tablets are prescribed to prevent blood clots in conditions such as non-valvular atrial fibrillation, thereby reducing the risk of stroke. They are also effective in treating deep vein thrombosis (DVT) and pulmonary embolism (PE). The active ingredient, edoxaban, inhibits Factor Xa, a crucial component in the blood clotting process. This 60 mg dosage is typically recommended for patients with normal kidney function and body weight over 60 kg. It's essential to follow your healthcare provider's instructions regarding dosage and duration of treatment to effectively manage and prevent thromboembolic events. . Please Note that product description, color, ingredients, package and other information maybe different from the original pack kindly check the product for more accurate details.
